Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Robotically Guided Left Ventricular Biopsy to Diagnose Cardiac Sarcoidosis: A Multidisciplinary Innovation Leading to First-in-Human Case.

Bhimaraj A, Trachtenberg B, Valderrábano M.

Circ Heart Fail. 2018 Mar;11(3):e004627. doi: 10.1161/CIRCHEARTFAILURE.117.004627. No abstract available.

PMID:
29519901
2.

Risk Stratification of Patients With Current Generation Continuous-Flow Left Ventricular Assist Devices Being Bridged to Heart Transplantation.

Guha A, Nguyen D, Cruz-Solbes AS, Amione-Guerra J, Schutt RC, Bhimaraj A, Trachtenberg BH, Park MH, Graviss EA, Gaber O, Suarez E, Montane E, Torre-Amione G, Estep JD.

ASAIO J. 2018 Mar/Apr;64(2):196-202. doi: 10.1097/MAT.0000000000000635.

PMID:
28885379
3.

Anemia after continuous-flow left ventricular assist device implantation: characteristics and implications.

Amione-Guerra J, Cruz-Solbes AS, Bhimaraj A, Trachtenberg BH, Pingali SR, Estep JD, Park MH, Guha A.

Int J Artif Organs. 2017 Sep 15;40(9):481-488. doi: 10.5301/ijao.5000607. Epub 2017 Jun 14.

PMID:
28623639
4.

Melding a High-Risk Patient for Continuous Flow Left Ventricular Assist Device into a Low-Risk Patient.

Amione-Guerra J, Cruz-Solbes AS, Gonzalez Bonilla H, Estep JD, Guha A, Bhimaraj A, Suarez EE, Bruckner BA, Torre-Amione G, Park MH, Trachtenberg BH.

ASAIO J. 2017 Nov/Dec;63(6):704-712. doi: 10.1097/MAT.0000000000000591.

PMID:
28504984
5.

Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension.

Segura-Ibarra V, Amione-Guerra J, Cruz-Solbes AS, Cara FE, Iruegas-Nunez DA, Wu S, Youker KA, Bhimaraj A, Torre-Amione G, Ferrari M, Karmouty-Quintana H, Guha A, Blanco E.

Int J Pharm. 2017 May 30;524(1-2):257-267. doi: 10.1016/j.ijpharm.2017.03.069. Epub 2017 Mar 28.

PMID:
28359821
6.

Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in "Real-World" Clinical Practice.

Desai AS, Bhimaraj A, Bharmi R, Jermyn R, Bhatt K, Shavelle D, Redfield MM, Hull R, Pelzel J, Davis K, Dalal N, Adamson PB, Heywood JT.

J Am Coll Cardiol. 2017 May 16;69(19):2357-2365. doi: 10.1016/j.jacc.2017.03.009. Epub 2017 Mar 19.

PMID:
28330751
7.

Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor.

Heywood JT, Jermyn R, Shavelle D, Abraham WT, Bhimaraj A, Bhatt K, Sheikh F, Eichorn E, Lamba S, Bharmi R, Agarwal R, Kumar C, Stevenson LW.

Circulation. 2017 Apr 18;135(16):1509-1517. doi: 10.1161/CIRCULATIONAHA.116.026184. Epub 2017 Feb 20.

8.

MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes.

Suresh Babu S, Thandavarayan RA, Joladarashi D, Jeyabal P, Krishnamurthy S, Bhimaraj A, Youker KA, Krishnamurthy P.

Sci Rep. 2016 Nov 9;6:36207. doi: 10.1038/srep36207.

9.

MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1.

Jeyabal P, Thandavarayan RA, Joladarashi D, Suresh Babu S, Krishnamurthy S, Bhimaraj A, Youker KA, Kishore R, Krishnamurthy P.

Biochem Biophys Res Commun. 2016 Mar 18;471(4):423-9. doi: 10.1016/j.bbrc.2016.02.065. Epub 2016 Feb 17.

10.

Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis.

Cordero-Reyes AM, Youker KA, Trevino AR, Celis R, Hamilton DJ, Flores-Arredondo JH, Orrego CM, Bhimaraj A, Estep JD, Torre-Amione G.

J Am Heart Assoc. 2016 Jan 14;5(1). pii: e002484. doi: 10.1161/JAHA.115.002484.

11.

Acquired and Hereditary Hypercoagulable States in Patients with Continuous Flow Left Ventricular Assist Devices: Prevalence and Thrombotic Complications.

Alvarez P, Cordero-Reyes AM, Uribe C, De Hoyos P, Martinez D, Bhimaraj A, Trachtenberg BH, Ashrith G, Torre-Amione G, Loebe M, Amione-Guerra J, Rice L, Estep JD.

J Card Fail. 2016 Jul;22(7):501-11. doi: 10.1016/j.cardfail.2015.12.020. Epub 2016 Jan 4.

PMID:
26762651
12.

Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.

Joladarashi D, Garikipati VNS, Thandavarayan RA, Verma SK, Mackie AR, Khan M, Gumpert AM, Bhimaraj A, Youker KA, Uribe C, Suresh Babu S, Jeyabal P, Kishore R, Krishnamurthy P.

J Am Coll Cardiol. 2015 Nov 17;66(20):2214-2226. doi: 10.1016/j.jacc.2015.09.009.

13.

Editorial: an interview with Dr. George P. Noon.

Bhimaraj A, Loebe M.

Methodist Debakey Cardiovasc J. 2015 Jan-Mar;11(1):45-7. doi: 10.14797/mdcj-11-1-45. No abstract available.

14.

Physiological impact of continuous flow on end-organ function: clinical implications in the current era of left ventricular assist devices.

Bhimaraj A, Uribe C, Suarez EE.

Methodist Debakey Cardiovasc J. 2015 Jan-Mar;11(1):12-7. doi: 10.14797/mdcj-11-1-12. Review.

15.

MDCT assessment of mechanical circulatory support device complications.

Vivo RP, Kassi M, Estep JD, Bhimaraj A, Trachtenberg BH, Orrego CM, Loebe M, Bruckner BA, Nabi F, Mahmarian JJ, Zoghbi WA, Chang SM.

JACC Cardiovasc Imaging. 2015 Jan;8(1):100-2. doi: 10.1016/j.jcmg.2014.06.023. Epub 2014 Oct 31. No abstract available.

16.

Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents.

Trachtenberg BH, Cordero-Reyes AM, Aldeiri M, Alvarez P, Bhimaraj A, Ashrith G, Elias B, Suarez EE, Bruckner B, Loebe M, Harris RL, Zhang JY, Torre-Amione G, Estep JD.

J Card Fail. 2015 Feb;21(2):119-25. doi: 10.1016/j.cardfail.2014.10.019. Epub 2014 Nov 6.

PMID:
25463739
17.

Ventricular assist devices: a review of psychosocial risk factors and their impact on outcomes.

Bruce CR, Delgado E, Kostick K, Grogan S, Ashrith G, Trachtenberg B, Estep JD, Bhimaraj A, Pham L, Blumenthal-Barby JS.

J Card Fail. 2014 Dec;20(12):996-1003. doi: 10.1016/j.cardfail.2014.09.006. Epub 2014 Sep 17. Review.

PMID:
25239054
18.

Echocardiographic Evaluation of Hemodynamics in Patients With Systolic Heart Failure Supported by a Continuous-Flow LVAD.

Estep JD, Vivo RP, Krim SR, Cordero-Reyes AM, Elias B, Loebe M, Bruckner BA, Bhimaraj A, Trachtenberg BH, Ashrith G, Torre-Amione G, Nagueh SF.

J Am Coll Cardiol. 2014 Sep 23;64(12):1231-41. doi: 10.1016/j.jacc.2014.06.1188.

19.

Treatment of cardiovascular complications of Alagille syndrome in clinical optimization for liver transplantation.

Smithson S, Hall D, Trachtenberg B, Bhimaraj A, Estep JD, Balzer DT, Lin CH.

Int J Cardiol. 2014 Sep 20;176(2):e37-40. doi: 10.1016/j.ijcard.2014.04.187. Epub 2014 May 15. No abstract available.

20.

A simplified echocardiographic technique for detecting continuous-flow left ventricular assist device malfunction due to pump thrombosis.

Estep JD, Vivo RP, Cordero-Reyes AM, Bhimaraj A, Trachtenberg BH, Torre-Amione G, Chang SM, Elias B, Bruckner BA, Suarez EE, Loebe M.

J Heart Lung Transplant. 2014 Jun;33(6):575-86. doi: 10.1016/j.healun.2014.01.865. Epub 2014 Jan 28.

PMID:
24656286
21.

Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation.

Estep JD, Cordero-Reyes AM, Bhimaraj A, Trachtenberg B, Khalil N, Loebe M, Bruckner B, Orrego CM, Bismuth J, Kleiman NS, Torre-Amione G.

JACC Heart Fail. 2013 Oct;1(5):382-8. doi: 10.1016/j.jchf.2013.06.002. Epub 2013 Sep 11.

22.

Revisiting surrogate consent for ventricular assist device placement.

Bruce CR, Bhimaraj A, Smith ML.

Ann Thorac Surg. 2014 Mar;97(3):747-9. doi: 10.1016/j.athoracsur.2013.12.039. No abstract available.

PMID:
24580897
23.

High proportion of patients with end-stage heart failure regardless of aetiology demonstrates anti-cardiac antibody deposition in failing myocardium: humoral activation, a potential contributor of disease progression.

Youker KA, Assad-Kottner C, Cordero-Reyes AM, Trevino AR, Flores-Arredondo JH, Barrios R, Fernandez-Sada E, Estep JD, Bhimaraj A, Torre-Amione G.

Eur Heart J. 2014 Apr;35(16):1061-8. doi: 10.1093/eurheartj/eht506. Epub 2013 Dec 29.

PMID:
24375073
24.

Increased right-to-left ventricle diameter ratio is a strong predictor of right ventricular failure after left ventricular assist device.

Vivo RP, Cordero-Reyes AM, Qamar U, Garikipati S, Trevino AR, Aldeiri M, Loebe M, Bruckner BA, Torre-Amione G, Bhimaraj A, Trachtenberg BH, Estep JD.

J Heart Lung Transplant. 2013 Aug;32(8):792-9. doi: 10.1016/j.healun.2013.05.016.

PMID:
23856216
25.

Treatment of acute tacrolimus toxicity with phenytoin in solid organ transplant recipients.

Jantz AS, Patel SJ, Suki WN, Knight RJ, Bhimaraj A, Gaber AO.

Case Rep Transplant. 2013;2013:375263. doi: 10.1155/2013/375263. Epub 2013 Jun 13.

26.

Remote monitoring of heart failure patients.

Bhimaraj A.

Methodist Debakey Cardiovasc J. 2013 Jan-Mar;9(1):26-31. Review.

27.

Amyloid heart disease: the deathly protein invasion--a personal perspective.

Bhimaraj A.

Methodist Debakey Cardiovasc J. 2012 Jul-Sep;8(3):19-20. No abstract available.

28.

Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.

Estep JD, Bhimaraj A, Cordero-Reyes AM, Bruckner B, Loebe M, Torre-Amione G.

Methodist Debakey Cardiovasc J. 2012 Jul-Sep;8(3):8-16. Review.

29.

Imaging for ventricular function and myocardial recovery on nonpulsatile ventricular assist devices.

Estep JD, Chang SM, Bhimaraj A, Torre-Amione G, Zoghbi WA, Nagueh SF.

Circulation. 2012 May 8;125(18):2265-77. doi: 10.1161/CIRCULATIONAHA.111.040238. Review. No abstract available.

30.

Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure.

Bhimaraj A, Tang WH.

Heart Fail Clin. 2012 Jan;8(1):101-11. doi: 10.1016/j.hfc.2011.08.003. Epub 2011 Oct 22. Review.

31.

How to deal with presensitized candidates for heart transplantation?

Bhimaraj A, Taylor DO.

Curr Opin Organ Transplant. 2011 Oct;16(5):529-35. doi: 10.1097/MOT.0b013e32834a8c4d. Review.

PMID:
21836519
33.

Bacillus Cereus Endocarditis in a permanent pacemaker: a case report.

Abusin S, Bhimaraj A, Khadra S.

Cases J. 2008 Aug 18;1(1):95. doi: 10.1186/1757-1626-1-95.

35.

Impact of organizational infrastructure on beta-blocker and aspirin therapy for acute myocardial infarction.

Ellerbeck EF, Bhimaraj A, Hall S.

Am Heart J. 2006 Sep;152(3):579-84.

PMID:
16923434
36.

Organization of care for acute myocardial infarction in rural and urban hospitals in Kansas.

Ellerbeck EF, Bhimaraj A, Perpich D.

J Rural Health. 2004 Fall;20(4):363-7.

PMID:
15551853

Supplemental Content

Loading ...
Support Center